Concepedia

Iwona E. Weidlich

IE

Statistics

Publications

6

Citations

200

H-Index

6

Active since

2009

Affiliations

National Cancer Institute(Current)

Center for Cancer Research

National Institutes of Health

Science Applications International Corporation (United States)

Frederick National Laboratory for Cancer Research

Iwona E. Weidlich is an author at National Cancer Institute specializing in medicinal chemistry, pharmacy, and drug discovery.

ORCID

Publications per year

2009–2016

6

Publications

6

PDB Ligand Conformational Energies Calculated Quantum-Mechanically

Markus Sitzmann, Iwona E. Weidlich, Igor Filippov et al. · Journal of Chemical Information and Modeling · 2012 · 64 citations · Full text

, , +17

4-Pregnen-21-ol-3,20-dione-21-(4-bromobenzenesufonate) (NSC 88915) and Related Novel Steroid Derivatives as Tyrosyl-DNA Phosphodiesterase (Tdp1) Inhibitors

Thomas S. Dexheimer, Lalji K. Gediya, Andrew G. Stephen et al. · Journal of Medicinal Chemistry · 2009 · 53 citations · Full text

, , +15

Inhibitors of human tyrosyl-DNA phospodiesterase (hTdp1) developed by virtual screening using ligand-based pharmacophores

Iwona E. Weidlich, Thomas S. Dexheimer, Christophe Marchand et al. · Bioorganic & Medicinal Chemistry · 2009 · 28 citations · Full text

, , +14

Inhibitors for the hepatitis C virus RNA polymerase explored by SAR with advanced machine learning methods

Iwona E. Weidlich, Igor Filippov, Jodian A. Brown et al. · Bioorganic & Medicinal Chemistry · 2013 · 25 citations · Full text

, , +14

Using the gini coefficient to measure the chemical diversity of small‐molecule libraries

Iwona E. Weidlich, Igor Filippov · Journal of Computational Chemistry · 2016 · 20 citations

, , +14

1–5 of 6